Medidata Solutions (MDSO) 35.93 $MDSO
Medidata to Present at 42nd Annual J.P. Morgan Global Technology, Media and Telecom Conference
Business Wire - Tue May 13, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will present at the 42nd Annual J.P. Morgan Global Technology, Media and Telecom Conference on May 19, 2014, at 1:00 p.m. ET in Boston, MA.
Medidata Solutions Has Returned 39.7% Since SmarTrend Recommendation (MDSO)
Comtex SmarTrend(R) - Fri May 09, 9:37AM CDT
SmarTrend identified a Downtrend for Medidata Solutions (NASDAQ:MDSO) on March 26th, 2014 at $56.49. In approximately 1 month, Medidata Solutions has returned 39.74% as of today's recent price of $34.04.
LabStyle Innovations Welcomes Professor Steven Kaplan to its Board of Directors
PR Newswire - Mon May 05, 7:55AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that world-renowned urologist and researcher, and co-founded numerous technology initiatives Professor Steven Kaplan, has joined the company's Board of Directors.
Medidata to Present at Jefferies 2014 Global Technology, Media & Telecom Conference
Business Wire - Thu May 01, 7:31AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Cory Douglas, chief financial officer, and Bryan Spielman, executive vice president of strategy and corporate development, will present at the Jefferies 2014 Global Technology, Media & Telecom Conference on May 7, 2014, at 1:00 p.m. ET in Miami, FL.
Were Medidata Solutions, Inc. Earnings Really That Bad?
Brian Stoffel, The Motley Fool - Motley Fool - Wed Apr 30, 5:30PM CDT
Medidata Solutions, Inc. shareholders just endured a pretty tough week. Though shares were up 300% over the last three years, they lost about one-quarter of that value last Tuesday alone. The company focuses on providing cloud solutions for drug...
Sanofi Expands Use of Medidata's Cloud-Based Platform to Advance Cutting-Edge Clinical Development
Business Wire - Mon Apr 28, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Sanofi, one of the world's top pharmaceutical companies, has increased its adoption of the Medidata Clinical Cloud(TM) as part of a company-wide initiative to achieve cutting-edge productivity across its global R&D organization. Sanofi, a Medidata enterprise client, will now leverage Medidata's best-in-class technology for risk-based monitoring of clinical trial sites, in addition to the broad set of solutions and analytics already used through the Medidata platform to improve operational efficiencies, resource savings and decision making.
3 Stocks Crushed by the Market This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Apr 26, 7:00AM CDT
Some stocks dipped this week. Some corrected. But three health-care stocks, in particular, were downright crushed. This week's biggest loser also ranked among the worst-performing stocks from a couple of weeks ago. Momentum works going up -- and...
Earnings Releases, Company Updates, and Strategic Partnerships - Analyst Notes on Medidata, LinkedIn, Qihoo 360, Cree and Lexmark
PR Newswire - Fri Apr 25, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Medidata Solutions, Inc. (NASDAQ: MDSO), LinkedIn Corporation (NYSE: LNKD), Qihoo 360 Technology Co. Ltd. (NYSE: QIHU), Cree, Inc. (NASDAQ: CREE) and Lexmark International Inc. (NYSE: LXK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1657-100free.
Downtrend Call Working As Medidata Solutions Stock Falls 27.3% (MDSO)
Comtex SmarTrend(R) - Thu Apr 24, 4:50PM CDT
SmarTrend identified a Downtrend for Medidata Solutions (NASDAQ:MDSO) on March 26th, 2014 at $56.49. In approximately 4 weeks, Medidata Solutions has returned 27.26% as of today's recent price of $41.09.
Earnings Roundup: Does Medidata's Stumble Present An Opportunity?
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 24, 1:00PM CDT
There's a land grab for market share in the health care IT industry that's trouncing margins and earnings and, in the process, erasing market cap at some of the industry's biggest players. The latest casualty is Medidata , a health care software...
3 Stocks Rising on Big Volume
at The Street - Thu Apr 24, 8:18AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Technical Data on Top Gainers -- Research on SUPERVALU, AK Steel Holding, Medidata Solutions, and Xoom
PR Newswire - Thu Apr 24, 7:23AM CDT
The trading session on Wednesday, April 23, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,501.65, down 0.08% and the NASDAQ Composite closed at 4,126.97, down 0.83%. The S&P 500 finished the session 0.22% lower at 1,875.39. During the session, Telecommunication Services, Information Technology, and Health Care sectors exerted a drag, while some positive momentum was observed in the Energy, Industrials, and Financials sectors. A number of stocks saw large movements, including SUPERVALU Inc. (NYSE: SVU), AK Steel Holding Corp. (NYSE: AKS), Medidata Solutions Inc. (NASDAQ: MDSO) and Xoom Corp. (NASDAQ: XOOM). Free technical research on SVU, AKS, MDSO and XOOM can be downloaded upon signing up at:
Medidata Solutions (MDSO) Marked As A Dead Cat Bounce Stock
at The Street - Wed Apr 23, 9:54AM CDT
Trade-Ideas LLC identified Medidata Solutions (MDSO) as a "dead cat bounce" (down big yesterday but up big today) candidate
Will This Price Target Cut Hurt Medidata Solutions (MDSO) Today?
at The Street - Wed Apr 23, 7:02AM CDT
Medidata Solutions (MDSO) has had its price target decreased to $50 from $72.50, Jefferies said Wednesday. The firm said though first-quarter results were disappointing analysts are reiterating a "buy."
Upgrade Alert for Medidata Solutions (MDSO)
Comtex SmarTrend(R) - Wed Apr 23, 6:58AM CDT
Medidata Solutions (NASDAQ:MDSO) was upgraded from Neutral to Buy at B. Riley today. The stock closed yesterday at $40.71 on volume of 10.5 million shares, above average daily volume of 720,000. Medidata Solutions (NASDAQ:MDSO) has potential upside of 65.7% based on a current price of $40.71 and analysts' consensus price target of $67.44. The stock should run into initial resistance at its 50-day moving average (MA) of $58.06 and subsequent resistance at its 200-day MA of $81.43.
Why Arch Coal, Medidata Solutions, and bebe stores Tumbled Today
Dan Caplinger, The Motley Fool - Motley Fool - Tue Apr 22, 7:35PM CDT
Overall, first-quarter earnings season has gone well for the stock market, and Tuesday continued to bring more good news than bad to investors looking at the state of corporate America and its impact on the U.S. economy. Yet, even though the Dow and...
ATTENTION MEDIDATA SHAREHOLDERS: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Medidata Solutions, Inc.
Business Wire - Tue Apr 22, 4:09PM CDT
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of federal securities laws by Medidata Solutions, Inc. (NASDAQ: MDSO) and certain of its officers. Medidata provides cloud-based clinical development solutions for life sciences.
Watch for Medidata Solutions to Potentially Rebound After Falling 22.74% Yesterday
Comtex SmarTrend(R) - Tue Apr 22, 3:50PM CDT
Medidata Solutions (NASDAQ:MDSO) traded in a range yesterday that spanned from a low of $37.15 to a high of $43.50. Yesterday, the shares fell 22.7%, which took the trading range below the 3-day low of $48.20 on volume of 10.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Why Medidata Solutions Inc. Shares Got Crushed
Brian Pacampara, The Motley Fool - Motley Fool - Tue Apr 22, 12:40PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Medidata Solutions plummeted 25% on...
Medidata to Present at 42nd Annual J.P. Morgan Global Technology, Media and Telecom Conference
Business Wire - Tue May 13, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will present at the 42nd Annual J.P. Morgan Global Technology, Media and Telecom Conference on May 19, 2014, at 1:00 p.m. ET in Boston, MA.
Medidata Solutions Has Returned 39.7% Since SmarTrend Recommendation (MDSO)
Comtex SmarTrend(R) - Fri May 09, 9:37AM CDT
SmarTrend identified a Downtrend for Medidata Solutions (NASDAQ:MDSO) on March 26th, 2014 at $56.49. In approximately 1 month, Medidata Solutions has returned 39.74% as of today's recent price of $34.04.
LabStyle Innovations Welcomes Professor Steven Kaplan to its Board of Directors
PR Newswire - Mon May 05, 7:55AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that world-renowned urologist and researcher, and co-founded numerous technology initiatives Professor Steven Kaplan, has joined the company's Board of Directors.
Medidata to Present at Jefferies 2014 Global Technology, Media & Telecom Conference
Business Wire - Thu May 01, 7:31AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Cory Douglas, chief financial officer, and Bryan Spielman, executive vice president of strategy and corporate development, will present at the Jefferies 2014 Global Technology, Media & Telecom Conference on May 7, 2014, at 1:00 p.m. ET in Miami, FL.
Were Medidata Solutions, Inc. Earnings Really That Bad?
Brian Stoffel, The Motley Fool - Motley Fool - Wed Apr 30, 5:30PM CDT
Medidata Solutions, Inc. shareholders just endured a pretty tough week. Though shares were up 300% over the last three years, they lost about one-quarter of that value last Tuesday alone. The company focuses on providing cloud solutions for drug...
Sanofi Expands Use of Medidata's Cloud-Based Platform to Advance Cutting-Edge Clinical Development
Business Wire - Mon Apr 28, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Sanofi, one of the world's top pharmaceutical companies, has increased its adoption of the Medidata Clinical Cloud(TM) as part of a company-wide initiative to achieve cutting-edge productivity across its global R&D organization. Sanofi, a Medidata enterprise client, will now leverage Medidata's best-in-class technology for risk-based monitoring of clinical trial sites, in addition to the broad set of solutions and analytics already used through the Medidata platform to improve operational efficiencies, resource savings and decision making.
3 Stocks Crushed by the Market This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Apr 26, 7:00AM CDT
Some stocks dipped this week. Some corrected. But three health-care stocks, in particular, were downright crushed. This week's biggest loser also ranked among the worst-performing stocks from a couple of weeks ago. Momentum works going up -- and...
Earnings Releases, Company Updates, and Strategic Partnerships - Analyst Notes on Medidata, LinkedIn, Qihoo 360, Cree and Lexmark
PR Newswire - Fri Apr 25, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Medidata Solutions, Inc. (NASDAQ: MDSO), LinkedIn Corporation (NYSE: LNKD), Qihoo 360 Technology Co. Ltd. (NYSE: QIHU), Cree, Inc. (NASDAQ: CREE) and Lexmark International Inc. (NYSE: LXK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1657-100free.
Downtrend Call Working As Medidata Solutions Stock Falls 27.3% (MDSO)
Comtex SmarTrend(R) - Thu Apr 24, 4:50PM CDT
SmarTrend identified a Downtrend for Medidata Solutions (NASDAQ:MDSO) on March 26th, 2014 at $56.49. In approximately 4 weeks, Medidata Solutions has returned 27.26% as of today's recent price of $41.09.
Earnings Roundup: Does Medidata's Stumble Present An Opportunity?
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 24, 1:00PM CDT
There's a land grab for market share in the health care IT industry that's trouncing margins and earnings and, in the process, erasing market cap at some of the industry's biggest players. The latest casualty is Medidata , a health care software...
3 Stocks Rising on Big Volume
at The Street - Thu Apr 24, 8:18AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Technical Data on Top Gainers -- Research on SUPERVALU, AK Steel Holding, Medidata Solutions, and Xoom
PR Newswire - Thu Apr 24, 7:23AM CDT
The trading session on Wednesday, April 23, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,501.65, down 0.08% and the NASDAQ Composite closed at 4,126.97, down 0.83%. The S&P 500 finished the session 0.22% lower at 1,875.39. During the session, Telecommunication Services, Information Technology, and Health Care sectors exerted a drag, while some positive momentum was observed in the Energy, Industrials, and Financials sectors. A number of stocks saw large movements, including SUPERVALU Inc. (NYSE: SVU), AK Steel Holding Corp. (NYSE: AKS), Medidata Solutions Inc. (NASDAQ: MDSO) and Xoom Corp. (NASDAQ: XOOM). Free technical research on SVU, AKS, MDSO and XOOM can be downloaded upon signing up at:
Medidata Solutions (MDSO) Marked As A Dead Cat Bounce Stock
at The Street - Wed Apr 23, 9:54AM CDT
Trade-Ideas LLC identified Medidata Solutions (MDSO) as a "dead cat bounce" (down big yesterday but up big today) candidate
Will This Price Target Cut Hurt Medidata Solutions (MDSO) Today?
at The Street - Wed Apr 23, 7:02AM CDT
Medidata Solutions (MDSO) has had its price target decreased to $50 from $72.50, Jefferies said Wednesday. The firm said though first-quarter results were disappointing analysts are reiterating a "buy."
Upgrade Alert for Medidata Solutions (MDSO)
Comtex SmarTrend(R) - Wed Apr 23, 6:58AM CDT
Medidata Solutions (NASDAQ:MDSO) was upgraded from Neutral to Buy at B. Riley today. The stock closed yesterday at $40.71 on volume of 10.5 million shares, above average daily volume of 720,000. Medidata Solutions (NASDAQ:MDSO) has potential upside of 65.7% based on a current price of $40.71 and analysts' consensus price target of $67.44. The stock should run into initial resistance at its 50-day moving average (MA) of $58.06 and subsequent resistance at its 200-day MA of $81.43.
Why Arch Coal, Medidata Solutions, and bebe stores Tumbled Today
Dan Caplinger, The Motley Fool - Motley Fool - Tue Apr 22, 7:35PM CDT
Overall, first-quarter earnings season has gone well for the stock market, and Tuesday continued to bring more good news than bad to investors looking at the state of corporate America and its impact on the U.S. economy. Yet, even though the Dow and...
ATTENTION MEDIDATA SHAREHOLDERS: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Medidata Solutions, Inc.
Business Wire - Tue Apr 22, 4:09PM CDT
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of federal securities laws by Medidata Solutions, Inc. (NASDAQ: MDSO) and certain of its officers. Medidata provides cloud-based clinical development solutions for life sciences.
Watch for Medidata Solutions to Potentially Rebound After Falling 22.74% Yesterday
Comtex SmarTrend(R) - Tue Apr 22, 3:50PM CDT
Medidata Solutions (NASDAQ:MDSO) traded in a range yesterday that spanned from a low of $37.15 to a high of $43.50. Yesterday, the shares fell 22.7%, which took the trading range below the 3-day low of $48.20 on volume of 10.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Why Medidata Solutions Inc. Shares Got Crushed
Brian Pacampara, The Motley Fool - Motley Fool - Tue Apr 22, 12:40PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Medidata Solutions plummeted 25% on...
